With the application of clinically available
genetic testing technologies, just over half of the patients referred to a genetics clinic receive a diagnosis. Without an accurate diagnosis,
there is little hope for an effective treatment.
Sequencing technologies have advanced rapidly, and GGC’s sequencing program proposes a unique and systematic approach to leverage these technological
advances with other novel and emerging technologies to improve that diagnostic rate by 20% over three years - growth that is unprecedented
in the world of clinical genetics.
GGC’s recently acquired NovaSeqTM instrument (pictured right) allows scientists to discover genetic changes throughout the entirety of a patient’s
genome. The Infinium® MethylationEPIC BeadChip instrument will discover how DNA is modified to cause changes in gene expression.
Back to Journey of Discovery